SCHEMBL16259019

SCHEMBL16259019

CC(C)SCC(N)C(=O)NCC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
MAPT P10636 2/20 0.50
LMNA P02545 1/20 0.50
PTGS2 P35354 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
ECE1 P42892 2/20 0.44
MME P08473 6/20 0.43
ACE P12821 4/20 0.43
CPA1 P15085 1/20 0.43
ACE2 Q9BYF1 1/20 0.43
METAP2 P50579 2/20 0.38
METAP1 P53582 2/20 0.38
PTGS1 P23219 1/20 0.38
GSTK1 Q9Y2Q3 1/20 0.38
GLO1 Q04760 2/20 0.36
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MEN1 O00255 1/20 0.35
BLM P54132 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16259012 1.00 ALDH1A1 (0.50) ALDH1A1MAPTLMNAPTGS2TDP1
SCHEMBL25892959 0.85 METAP2 (0.38) ALDH1A1MAPTLMNAPTGS2TDP1
SCHEMBL25868293 0.84 METAP2 (0.37) ALDH1A1MAPTLMNAPTGS2TDP1
SCHEMBL25868292 0.84 METAP2 (0.37) ALDH1A1MAPTLMNAPTGS2TDP1
SCHEMBL16260027 0.82 ALDH1A1 (0.50) ALDH1A1MAPTLMNAPTGS2TDP1
SCHEMBL16259997 0.82 ALDH1A1 (0.50) ALDH1A1MAPTLMNAPTGS2TDP1
SCHEMBL15824013 0.82 ALDH1A1 (0.43) ALDH1A1MAPTLMNAPTGS2TDP1
SCHEMBL15824510 0.82 ALDH1A1 (0.43) ALDH1A1MAPTLMNAPTGS2TDP1
SCHEMBL15846824 0.82 ALDH1A1 (0.43) ALDH1A1MAPTLMNAPTGS2TDP1
SCHEMBL15824512 0.82 ALDH1A1 (0.43) ALDH1A1MAPTLMNAPTGS2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9549911-B2 Ginger metabolites and uses thereof NORTH CAROLINA A&T STATE UNIVERSITY (US) 2017-01-24 US disclosed
US-9468625-B2 Organonitro thioether compounds and medical uses thereof EPICENTRX, INC. (US) 2016-10-18 US disclosed
US-20160081981-A1 ORGANONITRO THIOETHER COMPOUNDS AND MEDICAL USES THEREOF RADIORX, INC. 2016-03-24 US disclosed
US-9139519-B2 Organonitro thioether compounds and medical uses thereof EPICENTRX, INC. (US) 2015-09-22 US disclosed
US-20140349988-A1 ORGANONITRO THIOETHER COMPOUNDS AND MEDICAL USES THEREOF RADIORX, INC. (US) 2014-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140349988-A1 ORGANONITRO THIOETHER COMPOUNDS AND MEDICAL USES THEREOF SLC22A8, SLCO2A1, SLCO2B1 ALDH1A1 1453/4885MAPT 2777/4885LMNA 4706/4885
US-20160081981-A1 ORGANONITRO THIOETHER COMPOUNDS AND MEDICAL USES THEREOF SLC22A8, XPOT, NPM1 ALDH1A1 2447/4885MAPT 2770/4885LMNA 4550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.